Advisory board membership is a voluntary, independent, and non-remunerated position.
Dr. Curtis W. Dewey
Dr. Curtis Dewey, DVM, MS, from Cornell University, New York, is a Diplomate of the American College of Veterinary Internal Medicine (Neurology), a Diplomate of the American College of Veterinary Surgeons, and an Associate Professor at the Section of Neurology/Neurosurgery in the veterinary faculty of Cornell University, Ithaca, New York, U.S.A. Dr. Dewey’s main research interests include seizure management, congenital disorders of the central nervous system, and complementary therapies for neurologic disease. Species focus is on dogs and cats.
David P.D. Woldbye
David P.D. Woldbye is associate professor at the Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Denmark. He is the head of a research group presently studying effects of neuropeptides in animal models of epilepsy and Parkinson’s disease. His specific expertise comprises gene therapy with viral vectors, primary cell cultures, in situ hybridization, receptor autoradiography, functional binding assays, and in vivo microdialysis. The research group includes Post-Docs and PhD students. David is the author of more than 80 publications in international journals, an active reviewer of manuscripts, and member of several academic boards. He is one of the scientific founders of CombiGene AB, which provides the basis for Panion’s canine epilepsy gene therapy drug candidate.
Dr. Karen Munana
Dr. Karen Munana, Professor in neurology at North Carolina State University, College of veterinary medicine. She is a Doctor of Veterinary Medicine and holds a diplomate degree from the American College of Veterinary Internal Medicine (Neurology). She leads the Companion Animal Epilepsy Research Laboratory at NCSU, which is dedicated to developing more effective treatments for seizures in companion animals and to learn more about the cause of epileptic seizures in dogs and cats.